Scandinavian Biopharma awarded and qualified “Gazelle Company” by Dagens Industri

We are excited to share that we have been awarded the honourable title Gazelle company by Dagens Industri, DI. This means that we belong to the fastest growing companies in Sweden that are financially profitable with strong financial position.

DI Gasell is a prize that is awarded by the financial newspaper Dagens Industri to Sweden’s fastest growing companies. During autumn, DI is arranging gazelle gala’s in each county and at the final one held in Stockholm, the “Super Gazelle” is appointed to the fastest growing company in Sweden over the last three years. DI wants to draw attention to companies that create job opportunities, drive Sweden’s growth and at the same time inspire others to follow in the same footsteps.

The American economist and author David Birch first coined the term gazelle in the 1980s. He concluded that the small fast-growing businesses are the ones that generate the most jobs. Less than one percent of all companies in Sweden meet the criteria’s set by DI.

In 2018, Scandinavian Biopharma’s distribution operations set a new sales record. Sales increased from SEK 51.3 million in 2017 to SEK 81.3 million in 2018, which corresponds to an organic growth of 58%. Since Scandinavian Biopharma was founded in late 2009, the business has had a fantastic development and been profitable since 2013. The company has had an annual positive growth since 2013 with a total of 338 percent. The strong progression has continued during 2019 and we are looking forward to 2020 with confidence.



Go to MyNewsdesk

We are a research-based specialty biopharma company determined to give people worldwide a longer and better life.